HISTOGENICS CORP Intellectual Property Contracts & Agreements
17 Contracts & Agreements
- License Agreements (17 contracts)
- Second Amendment to the Exclusive License Agreement by and between the Registrant and The Washington University, dated as of November 28, 2023 (Filed With SEC on April 16, 2024)
- Exclusive License Agreement by and between Ocugen, Inc. and The Washington University, dated as of September 23, 2022 (Filed With SEC on November 8, 2022)
- Exclusive License Agreement, effective as of December 19, 2017, between The Schepens Eye Research Institute, Inc and Ocugen, Inc (Filed With SEC on June 14, 2019)
- Exclusive License Agreement, effective as of February 3, 2016, between The Board of Trustees of the University of Illinois and Ocugen, Inc (Filed With SEC on June 14, 2019)
- First Amendment to the Exclusive License Agreement, dated as of January 3, 2017, by and between The Regents of the University of Colorado and Ocugen, Inc (Filed With SEC on June 14, 2019)
- Exclusive License Agreement, effective as of March 3, 2014, between The Regents of the University of Colorado and Ocugen, Inc (Filed With SEC on June 14, 2019)
- License and Commercialization Agreement dated as of December 21, 2017 between the Company and MEDINET Co., Ltd (Filed With SEC on March 15, 2018)
- CONFIDENTIAL TREATMENT REQUESTED AMENDMENT NO. 3 TO THE LICENSE AGREEMENT EFFECTIVE 04/15/2001 BETWEEN STANFORD UNIVERSITY AND HISTOGENICS CORPORATION (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED Paid-up License Agreement (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED EIGHTH AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED SEVENTH AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED REINSTATEMENT AGREEMENT AND SIXTH AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED FIFTH AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED FOURTH AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED THIRD AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED SECOND AMENDMENT TO LICENSE AGREEMENT (Filed With SEC on October 7, 2014)
- CONFIDENTIAL TREATMENT REQUESTED LICENSE AGREEMENT (Filed With SEC on October 7, 2014)
